Coronavirus Update: Novovax, J&J Pen Deals With U.K. for Vaccine Delivery

Author:
Publish date:
Video Duration:
1:47

Good morning, it’s Friday, August 14. I’m Katherine Ross and here’s your daily coronavirus update.

There are over 20.9 million cases of the virus worldwide, with over 760,000 deaths.

According to Johns Hopkins, the U.S. has surpassed 5.2 million cases with over 167,000 deaths.

According to the COVID-19 Tracking Project, there were 51,705 new cases reported Thursday. 880,729 new tests were reported. And 1,163 deaths were reported yesterday.

What You Need to Know

On Thursday, House Speaker Nancy Pelosi said that Democratic lawmakers and the White House remain "miles apart" in their stimulus talks. Senate lawmakers, meanwhile, followed House Democrats in adjourning for the summer break.

Britain issued quarantine orders on all travelers arriving from France and the Netherlands.

And China retail sales posted a surprise July decline, while industrial output extended its slump, raising questions about the pace of recovery in the world's second-largest economy.

Vaccine News

Novovax and Johnson & Johnson have both signed deals to deliver millions of doses of their vaccine candidates to the U.K.

The government ordered 60 million doses of Novavax’s late-stage experimental vaccine, which may be available as early as the first quarter of 2021, the company said in a statement Friday.

Separately, J&J’s Janssen unit said it received an order for 30 million doses of its own COVID-19 trial vaccine.

The agreements come as countries around the world continue to race to secure a viable COVID-19 vaccine, with news earlier this week that Russia had approved the world’s first vaccine, despite the lack of available data on said vaccine.

You can follow Katherine Ross on Twitter at @byKatherineRoss.

Read more from Katherine Ross here.

Watch More on the Coronavirus Pandemic From TheStreet.com: